Drug-loaded nanoparticles that specifically bind to phages infecting cancer-promoting bacteria found in colonic tumours augment the effects of chemotherapy against colorectal cancer in mice.
This is a preview of subscription content, access via your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$99.00 per year
only $8.25 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Arnold, M. et al. Gut 66, 683 (2017).
Carding, S. et al. Microb. Ecol. Health Dis. 26, 26191–26191 (2015).
Bridges, K. M. et al. Curr. Colorectal Cancer Rep. 15, 70–77 (2019).
Tilg, H. et al. Cancer Cell 33, 954–964 (2018).
Schwabe, R. F. & Jobin, C. Nat. Rev. Cancer 13, 800–812 (2013).
Liang, Q. et al. Clin. Cancer Res. 23, 2061 (2017).
Dos Reis, S. A. et al. Nutr. Res. 37, 1–19 (2017).
Bullman, S. et al. Science 358, 1443 (2017).
Zheng, D.-W. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-019-0423-2 (2019).
Heymann, D. Curr Opin Investig Drugs 7, 443–450 (2006).
Ursell, L. K. et al. J Allergy Clin Immunol 129, 1204–1208 (2012).
Mima, K. et al. Gut 65, 1973 (2016).
Nicholson, J. K. et al. Science 336, 1262 (2012).
About this article
Cite this article
Aggarwal, N., Hwang, I.Y. & Chang, M.W. Phage-boosted chemotherapy. Nat Biomed Eng 3, 680–681 (2019). https://doi.org/10.1038/s41551-019-0450-z